MedPath

HOSPICES CIVILS DE LYON

HOSPICES CIVILS DE LYON logo
🇫🇷France
Ownership
-
Established
1796-01-01
Employees
10K
Market Cap
-
Website
http://www.chu-lyon.fr

Clinical Trials

1.8k

Active:153
Completed:900

Trial Phases

6 Phases

Early Phase 1:1
Phase 1:99
Phase 2:71
+3 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (981 trials with phase data)• Click on a phase to view related trials

Not Applicable
706 (72.0%)
Phase 1
99 (10.1%)
Phase 2
71 (7.2%)
Phase 3
71 (7.2%)
Phase 4
31 (3.2%)
phase_1_2
1 (0.1%)
Early Phase 1
1 (0.1%)
phase_2_3
1 (0.1%)

Randomized, Single-blind Pilot Study Assessing the Effect of Cutaneous RESonance Stimulation SYMPAthetic and Parasympathetic Tone and Anxiety in Patients Admitted for Cardiac Surgery

Not yet recruiting
Conditions
Anxiety
First Posted Date
2025-07-17
Last Posted Date
2025-07-17
Lead Sponsor
Hospices Civils de Lyon
Target Recruit Count
62
Registration Number
NCT07070986
Locations
🇫🇷

Hopitallouis Pradel, Bron, France

Artificial Intelligence for Respiratory Infections SEverity Prediction

Active, not recruiting
Conditions
Infectious Respiratory Diseases
Hospitalized Patients
Adult Patients
First Posted Date
2025-07-02
Last Posted Date
2025-07-02
Lead Sponsor
Hospices Civils de Lyon
Target Recruit Count
52000
Registration Number
NCT07047768
Locations
🇫🇷

Hygiène, épidémiologie, infectiovigilance et prévention GHN, Hôpital Croix-Rousse, Lyon, France

Medical Literacy in TIA (Transient Ischemic Attack) Patients

Recruiting
Conditions
Transient Ischemic Attack
First Posted Date
2025-06-27
Last Posted Date
2025-07-14
Lead Sponsor
Hospices Civils de Lyon
Target Recruit Count
100
Registration Number
NCT07040761
Locations
🇫🇷

Pierre Wertheimer hospital, Bron, France

Intestinal Hyperechogenicity Confirmed by Evaluation of Gray Spectra

Not yet recruiting
Conditions
Echogenicity
Intestinal Foetus
First Posted Date
2025-06-26
Last Posted Date
2025-06-30
Lead Sponsor
Hospices Civils de Lyon
Target Recruit Count
50
Registration Number
NCT07039721
Locations
🇫🇷

Hôpital Edouard Herriot, Lyon, Rhone, France

Genotype/Phenotype Correlation of MORC2 Mutations

Recruiting
Conditions
Charcot Marie Tooth Disease
DIFGAN
Developmental Delay (Disorder)
Impaired Growth
Dysmorphic Facies and Axonal Neuropathy
First Posted Date
2025-06-26
Last Posted Date
2025-07-04
Lead Sponsor
Hospices Civils de Lyon
Target Recruit Count
45
Registration Number
NCT07038239
Locations
🇫🇷

CHU de Besançon, Besançon, France

🇫🇷

CHRU Brest, Brest, France

🇫🇷

CHU Grenoble, Grenoble, France

and more 9 locations
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 344
  • Next

News

Volition's Nu.Q® Cancer Test Shows Promise in Lung Cancer Screening and Pan-Cancer Detection

Volition has enrolled the first patient in a 500-patient validation study at National Taiwan University Hospital to evaluate Nu.Q® Cancer technology for distinguishing between malignant and benign pulmonary nodules in LDCT lung cancer screening.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.